These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1684220)

  • 1. Alzheimer's disease. In the beginning..
    Selkoe DJ
    Nature; 1991 Dec; 354(6353):432-3. PubMed ID: 1684220
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease. Short precursor shortens memory.
    Mattson MP; Furukawa K
    Nature; 1997 May; 387(6632):457-8. PubMed ID: 9168104
    [No Abstract]   [Full Text] [Related]  

  • 3. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
    Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S
    Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
    Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ
    Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
    Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
    J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alzheimer's disease and amyloid protein precursor gene].
    Yoshikai S; Sakaki Y
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):12-20. PubMed ID: 1900946
    [No Abstract]   [Full Text] [Related]  

  • 7. A decade of modeling Alzheimer's disease in transgenic mice.
    McGowan E; Eriksen J; Hutton M
    Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
    Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
    Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
    Morgan D; Diamond DM; Gottschall PE; Ugen KE; Dickey C; Hardy J; Duff K; Jantzen P; DiCarlo G; Wilcock D; Connor K; Hatcher J; Hope C; Gordon M; Arendash GW
    Nature; 2000 Dec 21-28; 408(6815):982-5. PubMed ID: 11140686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning and memory in transgenic mice modeling Alzheimer's disease.
    Ashe KH
    Learn Mem; 2001; 8(6):301-8. PubMed ID: 11773429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased plasma cholesterol levels during aging in transgenic mouse models of Alzheimer's disease.
    Wirths O; Thelen K; Breyhan H; Luzón-Toro B; Hoffmann KH; Falkai P; Lütjohann D; Bayer TA
    Exp Gerontol; 2006 Feb; 41(2):220-4. PubMed ID: 16307858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
    Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
    J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
    Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.
    Vepsäläinen S; Hiltunen M; Helisalmi S; Wang J; van Groen T; Tanila H; Soininen H
    Neurosci Lett; 2008 Jun; 438(2):216-20. PubMed ID: 18455870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice.
    Sohn JH; So JO; Kim H; Nam EJ; Ha HJ; Kim YH; Mook-Jung I
    Biochem Biophys Res Commun; 2007 Sep; 361(3):800-4. PubMed ID: 17678618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of beta-amyloid protein deposits in brains of transgenic mice.
    Quon D; Wang Y; Catalano R; Scardina JM; Murakami K; Cordell B
    Nature; 1991 Jul; 352(6332):239-41. PubMed ID: 1906990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Refolo LM; Pappolla MA; LaFrancois J; Malester B; Schmidt SD; Thomas-Bryant T; Tint GS; Wang R; Mercken M; Petanceska SS; Duff KE
    Neurobiol Dis; 2001 Oct; 8(5):890-9. PubMed ID: 11592856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gangliosides determine the amyloid pathology of Alzheimer's disease.
    Oikawa N; Yamaguchi H; Ogino K; Taki T; Yuyama K; Yamamoto N; Shin RW; Furukawa K; Yanagisawa K
    Neuroreport; 2009 Aug; 20(12):1043-6. PubMed ID: 19590389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.